Asia Pacific Protein Expression Market Report and Forecast 2025-2034

Asia Pacific Protein Expression Market Outlook

The global protein expression market size was valued at USD 3 billion in 2024, with Asia Pacific holding a significant market share. The market is driven by the increased protein-based research and development activities. It is expected to grow at a CAGR of 5.40% during the forecast period of 2025-2034, with the values likely to attain USD 4.9 billion by 2034.

Key Takeaways

• Recent studies suggest that 80% of the population aged 60 or above in China is affected by at least one chronic disease. The rising prevalence of such chronic conditions is expected to fuel market growth for protein expression systems.

• One of the major Asia Pacific protein expression market trends is increased investment in biologics manufacturing facilities, which is likely to stimulate technological advancement and innovation in protein expression technologies. In November 2023, an Indian CDMO Aragen Life Sciences announced the confirmation of USD 30 million for setting up a biologics manufacturing site in Bengaluru (India) to boost its bioproduction capabilities including the production of therapeutic proteins.

• In the Asia Pacific region, the rising demand for biologic drugs, including monoclonal antibodies and recombinant proteins, owing to the growing need for targeted therapeutics is expected to elevate market value in the coming years.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Asia Pacific Protein Expression Market Analysis

Protein expression can be defined as a process in which proteins are produced, modified, and regulated in living organisms. Protein expression technologies can be utilized to synthesize therapeutic proteins, antibodies, and other biologics for treating various diseases. Such technologies are also employed in the development and production of vaccines against infectious diseases. The increased application of protein expression systems to facilitate drug development, disease diagnosis, and personalized medicine, is significantly contributing to the Asia Pacific protein expression market growth.

In Asia Pacific, the burden of chronic diseases such as cancer, cardiovascular diseases, and diabetes, is increasing rapidly which can be attributed to the growing aging population, sedentary lifestyle, and environmental factors, among others. Recent studies suggest that 80% of the population aged years 60 or above in China is affected by at least one chronic disease. To manage these chronic conditions, effective treatment options in the form of monoclonal antibodies, recombinant proteins, and other biologics, are required. Protein expression systems are an essential component in the production of these therapeutic proteins. Thus, the rising prevalence of chronic diseases is expected to fuel the Asia Pacific protein expression market demand in the forecast period.

One of the major market trends is increased investment in biologics manufacturing facilities, which is likely to stimulate technological advancement and innovation in protein expression technologies. In November 2023, an India-based contract development and manufacturing organization Aragen Life Sciences announced the confirmation of USD 30 million for setting up a biologics manufacturing site in Bengaluru (India) to boost its bioproduction capabilities. The facility, spanning over 160,000 square feet, is also set to develop and produce fusion proteins as well as therapeutic proteins. Such substantial investments are poised to expand the capacity for protein expression and production, thereby augmenting the Asia Pacific protein expression market share.

The market is witnessing an increased demand for biologic drugs, including monoclonal antibodies and recombinant proteins in the Asia Pacific region, owing to the rising prevalence of chronic diseases and the need for targeted therapeutics. This directly impacts the market dynamics for protein expression technologies as they are essential to produce biologics. Further, the rising healthcare expenditures, advancements in biotechnology, and increased investment in research infrastructure are anticipated to accelerate market growth in the forecast period.

Asia Pacific Protein Expression Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Asia Pacific Protein Expression Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Merck KGaA

• Thermo Fisher Scientific Inc.

• GenScript Biotech Corporation

• Agilent Technologies, Inc.

• Takara Bio Inc.

• Bio-Rad Laboratories, Inc.

• QIAGEN

• Promega Corporation

• GE Healthcare

• Bioneer Corporation

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report